Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl-2 pathway

Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignant tumor type, and epigenetic modifications such as acetylation or deacetylation serve vital roles in its development. Chidamide, a novel histone deacetylase inhibitor, exerts an anticancer effect against various types of cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongwei, Chi, Fenqing, Qin, Keru, Mu, Xiuli, Wang, Lieyang, Yang, Bin, Wang, Yanli, Bai, Min, Li, Zhenhua, Su, Liping, Yu, Baofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974270/
https://www.ncbi.nlm.nih.gov/pubmed/33649847
http://dx.doi.org/10.3892/mmr.2021.11947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974270/
https://www.ncbi.nlm.nih.gov/pubmed/33649847
http://dx.doi.org/10.3892/mmr.2021.11947

Ejemplares similares